SC 13D Filing

Company

Opus Genetics, Inc.

Filed

August 18, 2004

Accession Number

0001144204-04-012557

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →